Insider · CIK 0001727723
Adam Sragovicz
Files at IDN (Intellicheck, Inc.), CDT (CONDUIT PHARMACEUTICALS INC.). First filing -, latest -.
In brief
Adam Sragovicz files SEC Form 4 as CFO at IDN (Intellicheck, Inc.), and also at CDT (CONDUIT PHARMACEUTICALS INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Adam Sragovicz has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 10, 2025 | IDN Intellicheck, Inc. | 18,628 0.09% of outstanding | $101k | Sep 10, 2025 | none |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 24, 2026 | IDN Intellicheck, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +100,351 | $0.00 | $0 | 100,351 | Mar 26, 2026 |
| Sep 10, 2025 | IDN Intellicheck, Inc. | MOption exercise Common Stock, $.001 par value | +45,429 | $2.21 | $100k | 55,429 | Sep 11, 2025 |
| Sep 10, 2025 | IDN Intellicheck, Inc. | FTax withholding Common Stock, $.001 par value | -18,628 | $5.41 | $101k | 36,801 | Sep 11, 2025 |
| Sep 10, 2025 | IDN Intellicheck, Inc. | MOption exercise Stock Option (Right to Buy)derivative | +45,249 | $0.00 | $0 | 45,249 | Sep 11, 2025 |
| Apr 25, 2025 | IDN Intellicheck, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +100,351 | $0.00 | $0 | 100,351 | Apr 29, 2025 |
| Dec 1, 2023 | CDT CONDUIT PHARMACEUTICALS INC. | AGrant or award Restricted Stock Units | +74,545 | - | - | 74,545 | Dec 5, 2023 |
Questions about Adam Sragovicz
Answered from the filings on this page, as of the latest one.
Is Adam Sragovicz buying or selling?
Adam Sragovicz has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Adam Sragovicz's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Adam Sragovicz has 0.
Where does Adam Sragovicz file Form 4?
Adam Sragovicz has filed Form 4 at IDN (Intellicheck, Inc.) as Chief Financial Officer; CDT (CONDUIT PHARMACEUTICALS INC.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.